Application 065180
- Type
- ANDA
- Sponsor
- WOCKHARDT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CEFTRIAXONE | CEFTRIAXONE SODIUM | INJECTABLE;INJECTION | EQ 1GM BASE/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A065180-001 | CEFTRIAXONE | CEFTRIAXONE SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A065180-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A065180-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2006-05-12 | f41ea6bd6efb… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A065180-001 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A065180-001 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A065180-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065180-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A065180-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065180-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065180-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065180-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065180-001 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065180-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065180-001 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A065180-001 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065180-001 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065180-001 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065180-001 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A065180-001 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065180-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A065180-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A065180-001 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A065180-001 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A065180-001 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A065180-001 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A065180-001 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A065180-001 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A065180-001 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A065180-001 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A065180-001 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A065180-001 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A065180-001 | AP | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A065180-001 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A065180-001 | AP | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A065180-001 | AP | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A065180-001 | AP | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A065180-001 | AP | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A065180-001 | AP | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A065180-001 | AP | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A065180-001 | AP | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A065180-001 | AP | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A065180-001 | AP | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A065180-001 | AP | 1 | f41ea6bd6efb… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | A-S Medication Solutions | 1aa0a4ee-1b39-4c3d-a7a3-33dded6fe28c | 2024-01-31 | Warnings, Adverse reactions | CEFTRIAXONE SODIUM |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | A-S Medication Solutions | ff8e830a-c288-46fb-9e19-ec2017943c07 | 2024-01-31 | Warnings, Adverse reactions | CEFTRIAXONE SODIUM |
| ceftriaxone | CEFTRIAXONE | Sagent Pharmaceuticals | 5cf93bc5-9e4c-4734-bc02-c7d0ac071022 | 2023-11-08 | Warnings, Adverse reactions | ceftriaxone |
| Ceftriaxone | CEFTRIAXONE | Fresenius Kabi USA, LLC | 7ea1db43-40fa-417b-8911-ae98092070a0 | 2023-09-30 | Warnings, Adverse reactions | Ceftriaxone |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Asclemed USA, Inc. | f01cf0e5-caaf-4759-ba21-50f3aceff523 | 2023-09-02 | Warnings, Adverse reactions | CEFTRIAXONE SODIUM |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Apotex Corp. | 5116231f-82d1-44be-b08e-560c9a50e5c5 | 2023-08-31 | Warnings, Adverse reactions | CEFTRIAXONE SODIUM |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Apotex Corp. | ac03a72c-0e35-40f9-b7fc-081badb5f19c | 2023-01-28 | Warnings, Adverse reactions | CEFTRIAXONE SODIUM |
| Ceftriaxone | CEFTRIAXONE SODIUM | Samson Medical Technologies, LLC | 5cd2d96f-83e5-4326-ae87-d0ede4ba493a | 2023-01-15 | Warnings, Adverse reactions | Ceftriaxone CEFTRIAXONE SODIUM |
| Ceftriaxone | CEFTRIAXONE | Proficient Rx LP | fcf401df-bcdc-4773-a63b-9741c0f74b3d | 2022-11-01 | Warnings, Adverse reactions | Ceftriaxone |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Proficient Rx LP | a25ab5ea-c46d-4562-8f7e-0ccffc2ab069 | 2022-10-01 | Warnings, Adverse reactions | CEFTRIAXONE SODIUM |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Proficient Rx LP | 42ba7a9d-7d2b-4eac-af59-897151a8c924 | 2022-05-02 | Warnings, Adverse reactions | CEFTRIAXONE SODIUM |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Hospira, Inc | 9d1f630b-e759-4395-9d01-ddc90e4fea75 | 2022-03-09 | Warnings, Adverse reactions | CEFTRIAXONE SODIUM |
| Ceftriaxone | CEFTRIAXONE | Hikma Pharmaceuticals USA Inc. | 8351aa37-552d-471d-b293-c564dcb6ec29 | 2021-12-01 | Warnings, Adverse reactions | Ceftriaxone |
| Ceftriaxone | CEFTRIAXONE | Hikma Pharmaceuticals USA Inc. | 1f8776bd-4f5b-427a-849a-6b8338f7997d | 2019-04-24 | Warnings, Adverse reactions | Ceftriaxone |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 55648-983 | CEFTRIAXONE | CEFTRIAXONE | Wockhardt Limited | ANDA | Current |
| 64679-983 | CEFTRIAXONE | CEFTRIAXONE | Wockhardt USA LLC. | ANDA | Current |
| 64679-983 | CEFTRIAXONE | CEFTRIAXONE | Wockhardt USA LLC. | ANDA | Current |
| 64679-983 | CEFTRIAXONE | CEFTRIAXONE | Wockhardt USA LLC. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 44218 | ORIG | 2008-09-19 |